Lamond David

CIK 00017707903 companiesSOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001770790

Recent Transactions

50 trades

Award
Quince Therapeutics, Inc.$QNCX
Director Stock Option (Right to Buy)
2026-01-02+29,423→ 29,423 total
Award
Quince Therapeutics, Inc.$QNCX
Director Stock Option (Right to Buy)
2025-06-04+27,000→ 27,000 total
Award
Quince Therapeutics, Inc.$QNCX
Director Stock Option (right to buy)
2025-01-02+47,587→ 47,587 total
Award
Quince Therapeutics, Inc.$QNCX
Employee Stock Option (right to buy)
2024-06-05+27,000→ 27,000 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-12-14$1.04/sh+22,627→ 2,347,545 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-12-13$1.00/sh+22,627→ 2,324,918 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-12-12$1.00/sh+300→ 2,279,964 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-12-12$1.02/sh+22,327→ 2,302,291 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-12-07$1.01/sh+19,123→ 2,279,664 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-12-06$1.02/sh+19,123→ 2,260,541 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-12-05$1.01/sh+19,123→ 2,241,418 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-12-01$0.94/sh+14,378→ 2,222,295 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-11-30$0.90/sh+14,378→ 2,207,917 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-11-29$0.98/sh+14,378→ 2,193,539 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-08-31$1.32/sh+41,026→ 2,179,161 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-08-30$1.31/sh+41,026→ 2,138,135 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-08-17$1.29/sh+24,766→ 2,097,109 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-08-16$1.29/sh+117,348→ 2,072,343 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2023-08-15$1.32/sh+107,886→ 1,954,995 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2023-05-24+27,000→ 27,000 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2022-06-08+27,000→ 27,000 total
Award
Lucira Health, Inc.
Stock Option (right to buy)
2022-06-01+59,459→ 59,459 total
Award
Applied Molecular Transport Inc.
Stock Option (Right to Buy)
2022-05-24+20,000→ 20,000 total
Purchase
Applied Molecular Transport Inc.
Common Stock
2022-05-23$3.26/sh+33,500→ 1,077,519 total
Purchase
Applied Molecular Transport Inc.
Common Stock
2022-05-20$3.08/sh+33,000→ 1,044,019 total
Award
Quince Therapeutics, Inc.$QNCX
Common Stock
2022-05-19+200,002→ 1,734,722 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (right to buy)
2021-06-16+11,029→ 11,029 total
Award
Applied Molecular Transport Inc.
Stock Option (Right to Buy)
2021-05-18+15,175→ 15,175 total
Purchase
Applied Molecular Transport Inc.
Common Stock
2021-04-06$42.00/sh+25,000→ 1,011,019 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-03-24$33.77/sh+50,000→ 1,847,109 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-03-04$35.00/sh+13,310→ 1,777,040 total
Gift
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-03-04+1,534,720→ 1,534,720 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-03-04$34.28/sh+16,621→ 1,763,730 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-03-04$36.34/sh+15,969→ 1,793,009 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2021-03-04$36.86/sh+4,100→ 1,797,109 total
Conversion
Lucira Health, Inc.
Common Stock
2021-02-09+53,629→ 53,629 total
Conversion
Lucira Health, Inc.
Series C Preferred Stock
2021-02-09−92,756→ 0 total
Conversion
Lucira Health, Inc.
Common Stock
2021-02-09+92,756→ 146,385 total
Conversion
Lucira Health, Inc.
Series B Preferred Stock
2021-02-09−53,629→ 0 total
Conversion
Applied Molecular Transport Inc.
Series B Preferred Stock
2020-06-09−1→ 0 total
Conversion
Applied Molecular Transport Inc.
Series C Preferred Stock
2020-06-09−1→ 0 total
Conversion
Applied Molecular Transport Inc.
Series A Preferred Stock
2020-06-09−1→ 0 total
Award
Applied Molecular Transport Inc.
Common Stock
2020-06-09$14.00/sh+71,430→ 986,019 total
Conversion
Applied Molecular Transport Inc.
Common Stock
2020-06-09+914,589→ 914,589 total
Award
Quince Therapeutics, Inc.$QNCX
Stock Option (Right to Buy)
2020-06-08+11,029→ 11,029 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-06-04$43.88/sh+24,874→ 1,747,109 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-06-04$43.32/sh+10,642→ 1,722,235 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-06-04$42.13/sh+13,609→ 1,711,593 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-05-19$55.42/sh+5,906→ 1,665,090 total
Purchase
Quince Therapeutics, Inc.$QNCX
Common Stock
2020-05-19$54.09/sh+400→ 1,659,184 total

Companies

Recent Filings

Address

C/O QUINCE THERAPEUTICS, INC. 611 GATEWAY BLVD., SUITE 273

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov